Regenerative Medical Group, Inc.
Regenerative Medical Group, Inc. was the subject of an FTC enforcement action alleging that the company deceptively advertised 'amniotic stem cell therapy' to consumers between 2014 and 2017. The FTC found the marketing claims to be deceptive and ordered consumer redress. As a result, the FTC mailed 270 checks totaling nearly $515,000 to harmed consumers, with an average payment of approximately $1,907 per consumer.
Flagged claims (1)
amniotic stem cell therapy
Required actions (1)
The FTC is mailing 270 checks totaling nearly $515,000 to consumers who paid for what the agency alleged was deceptively advertised "amniotic stem cell therapy" between 2014 and 2017.
Does your site contain similar claims?
The free site audit scans your whole site against every entry in this Atlas. Most stem cell / regenerative sites match 3-6 patterns.
Run my free site auditWorried about one specific page, ad, or email? Paste it into the free Claim Checker and see what the FDA and FTC would flag, with the precedent next to each one. No email required.
Check specific copy in the Claim Checker